Bioasis Technologies Inc. — Investor Relations & Filings
Filings indexed
120
across all filing types
Latest filing
2023-06-20
Regulatory Filings
Country
CA
Canada
Listing
TSXV
BIOAF
Bioasis Technologies Inc. is a development-stage biopharmaceutical company focused on the research and development of proprietary technologies and products for Central Nervous System (CNS) diseases and brain-related disorders. Its core technology is the xB3 platform, a proprietary system designed to facilitate the transport and delivery of therapeutic agents across the challenging blood-brain barrier (BBB). The company's in-house programs aim to develop both symptomatic and disease-modifying treatments, as well as diagnostic technologies, addressing the limitations inherent in treating complex neurological conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-06-20 | English | |
| News release - English.pdf | 2023-03-23 | English | |
| Material change report - English.pdf | 2023-02-01 | English | |
| News release - English.pdf | 2023-01-23 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13676673 | News release - English.pdf | 2023-06-20 | English | ||
| 13655121 | News release - English.pdf | 2023-03-23 | English | ||
| 13641805 | Material change report - English.pdf | 2023-02-01 | English | ||
| 26889150 | News release - English.pdf | 2023-01-23 | English | ||
| 13640993 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | ||
| 13640992 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English | ||
| 13641004 | Interim MD&A - English.pdf | 2023-01-19 | English | ||
| 13640995 | Interim financial statements/report – English.pdf | 2023-01-19 | English | ||
| 13640996 | News release - English.pdf | 2023-01-19 | English | ||
| 13640997 | News release - English.pdf | 2023-01-19 | English | ||
| 13638871 | News release - English.pdf | 2023-01-11 | English | ||
| 13638942 | Other.pdf | 2023-01-11 | English | ||
| 13638941 | Other.pdf | 2023-01-11 | English | ||
| 13638940 | Other.pdf | 2023-01-11 | English | ||
| 13638939 | Other.pdf | 2023-01-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
Bioasis Technologies Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46038/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46038 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46038 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46038 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46038}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bioasis Technologies Inc. (id: 46038)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.